Tctc Holdings, LLC Baxter International Inc Transaction History

Tctc Holdings, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$31.71 - $38.95 $314,309 - $386,072	-9,912 Reduced 99.0%	100 $3,000
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $169,059 - $223,283	-4,530 Reduced 31.15%	10,012 $377,000
Q1 2023 May 12, 2023	BUY	$37.58 - $52.57 $375,311 - $525,016	9,987 Added 219.25%	14,542 $589,000
Q4 2022 Feb 10, 2023	BUY	$49.7 - $57.71 $29,820 - $34,626	600 Added 15.17%	4,555 $232,000
Q1 2022 May 11, 2022	SELL	$76.85 - $89.45 $2,305 - $2,683	-30 Reduced 0.75%	3,955 $307,000
Q3 2021 Nov 04, 2021	BUY	$73.77 - $83.61 $2,213 - $2,508	30 Added 0.76%	3,985 $320,000
Q2 2020 Aug 12, 2020	SELL	$78.66 - $94.14 $57,107 - $68,345	-726 Reduced 15.51%	3,955 $340,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,681	4,681 $284,000

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Tctc Holdings, LLC with notifications on news.